Genetically engineered immune cells show promise for fighting relapsed blood cancer

(UNC Lineberger Comprehensive Cancer Center) At the 60th Annual American Society of Hematology Annual Meeting in San Diego on Monday, UNC Lineberger Comprehensive Cancer Center researchers presented preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news